# eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer

> **NCT05427240** · NA · RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 1000 (estimated)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Pre-Test Intervention
- **OTHER:** Standard of Care
- **OTHER:** Post-Test Intervention

## Key facts

- **NCT ID:** NCT05427240
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-28
- **Primary completion:** 2025-12-24
- **Final completion:** 2026-07-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05427240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05427240, "eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05427240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*